OakChart

Neuraxis Inc

NRXSHealthcare·Biotechnology·USA·Micro·AMEX·Nov 12 • 3:59 PM ET

5.75-0.28 (-4.64%)
2026-11-12 22:20 CET
Market cap
$81.62M
Revenue, TTM
6.53 USD m
Net income, TTM
-12.87 USD m
Free cash flow, TTM
-6.47 USD m
EPS diluted, TTM
-1.06
Price / earnings
-
Compare

Price

NRXS against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
Sales mean, own scale
RS 77Sales 2.20Price2.203.006.008.00564K1.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NRXSclose 5.7520-day 7.0150-day 6.89200-day 6.745.75

38.4% under the 52-week high of 9.33 on 5 May 2026. 52-week low 2.21 on 20 Nov 2025. Last 15 sessions, 39.4% high to low

Volume 1.35× normal · the line is the 50-bar volume average

Setup. RS line 77
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Institutional Ownership: Over 50%; Average Volume: Over 200K
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High; Relative Volume: Under 1
Minervini 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200
Accumulation 1 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200
Relative Strength 1 of 3 — fails: 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K

Profile

NRXS
52-week range, 50% of the way up
2.219.33

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.

Employees24
IPOAug 09, 2023
Beta1.41
ATR, 14d0.54
Rel volume1.35
Short float5.33%
Insider own31.94%
Inst own23.25%

Snapshot

6 groups

Valuation

Index-
Market Cap$81.62M
Enterprise Value77.57M
Income-12.87M
Sales6.53M
Book / share0.26
Cash / share0.32
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees24
IPOAug 09, 2023

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales12.50
Price / book21.94
Price / cash18.22
Price / free cash flow-
Value / cash profit-
Value / sales11.88
Quick Ratio2.01
Current Ratio2.10
Debt / equity0.12
Long-term debt / equity0.04
Options and shortYes / Yes

Earnings

Earnings / share-1.06
Earnings next year-0.56
Earnings next quarter-0.25
Earnings this year14.74%
Earnings next year30.86%
Earnings growth, 5 years-
Past earnings growth-1.64% -6.18%
Past sales growth9.96% 13.08%
Earnings vs last year-4.03%
Sales vs last year94.29%
Earnings vs last quarter-120.85%
Sales vs last quarter149.92%
EarningsNov 09 BMO
Surprise0.00% -3.43%

Ownership

Insiders own31.94%
Insider trades0.06%
Institutions own23.25%
Institution trades6.08%
Return on assets-194.69%
Return on equity-409.70%
Return on capital-321.23%
Gross Margin86.16%
Operating margin-186.16%
Profit Margin-197.02%
20-day average-17.96%
50-day average-16.60%
200-day average-14.71%

Technical

Shares out13.81M
Shares floating8.55M
Short / float5.33%
Short ratio3.45
Short interest0.46M
52-week high9.33 -38.4%
52-week low2.21 +160.2%
Volatility12.65% 8.03%
Average range0.54
Strength index35.04
Market sensitivity1.41
Relative volume1.35
Avg Volume132.06K
Volume178,666

Performance

Perf Week-5.89%
Perf Month-11.94%
Perf Quarter-8.73%
Perf Half Y-31.14%
Perf YTD26.65%
Perf Year121.15%
Perf 3Y125.49%
Perf 5Y-
Perf 10Y-
Recommendation1.00
Target Price13.00
Prev Close6.03
Price5.75
Change %-4.64%

Peers

Mkt cap
TickerCompanyMkt cap
ECORElectroCore Inc48.80M
NPCENeuroPace Inc412.58M
BWAYBrainsway Ltd ADR412.56M
NXLNexalin Technology Inc1.71M
INSPInspire Medical Systems Inc1.75B
LIVNLivaNova PLC4.97B
NMTCNeuroOne Medical Technologies Corp6.81M
ELMDElectromed Inc204.10M
FEMYFemasys Inc11.72M
IVFINVO Fertility Inc3.20M

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Carrico Brian AllenChief Executive OfficerOct 08 '26Buy4.842681,297227,604Oct 08 05:50 PM
Carrico Thomas JoesephCRO, CCO, CPOOct 08 '26Buy4.843281,588199,673Oct 08 05:47 PM
Henrichs Timothy RobertChief Financial OfficerOct 08 '26Buy4.841,9379,3759,530Oct 08 05:45 PM
Henrichs Timothy RobertChief Financial OfficerApr 01 '26Buy1.967,59314,8827,593Apr 03 11:23 AM
Carrico Thomas JoesephCRO, CCO, CPOApr 01 '26Buy1.966671,307331,903Apr 03 11:21 AM
Carrico Brian AllenChief Executive OfficerApr 01 '26Buy1.968,06015,798348,178Apr 03 11:19 AM
Hannasch Brian10% OwnerFeb 12 '26Buy4.9240,000196,8001,211,522Feb 13 04:04 PM
Hannasch Brian10% OwnerFeb 11 '26Buy4.6540,000186,0001,171,522Feb 13 04:04 PM
Aharon GilDirectorDec 23 '25Buy3.52286,1381,007,206286,138Dec 29 05:12 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWCiShares Micro-Cap ETFAUM: 1.23B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 112.81M

News

latest 14 of 200
  • NeurAxis Misses On Earnings As Rising Cash Burn And A Stock-Comp Charge Overshadow Accelerating Payer-Driven Growth (Earnings Whispers) +5.93%
  • NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth (GlobeNewswire)
  • NeurAxis Must Show Payer Momentum Can Outrun A Deliberate Rise In Spending (Earnings Whispers) -7.43%
  • NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026 (GlobeNewswire)
  • NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives (GlobeNewswire) +18.53%
  • NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer (GlobeNewswire)
  • NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives (GlobeNewswire) +21.75%
  • NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference (GlobeNewswire)
  • Is Kodak having a "Kodak moment?" 2 watchlist stocks. (Zacks)
  • iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 (ACCESSWIRE)
  • Neuraxis Inc (NRXS) (Q2 2026) Earnings Call Highlights: Revenue Surges 116% as Payer Coverage ... (GuruFocus.com) -7.57%
  • NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth (GlobeNewswire)
  • Earnings To Watch: Neuraxis Inc (NRXS) Q2 2026 -- GF Value Sees 55% Downside (GuruFocus.com)
  • NeurAxis Expands Payer Coverage with New Policies (GlobeNewswire) +6.37%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.210-0.210-0.5192.032.101
2026Q22026-08-11-0.190-0.320-0.1881.932.002
2026Q12026-05-12-0.180-0.190-0.1781.611.452
2025Q42026-03-19-0.180-0.215-0.1790.970.852
2025Q32025-11-11-0.240-0.200-0.2350.811.002
2025Q22025-08-12-0.220-0.190-0.2230.890.982
2025Q12025-05-12-0.330-0.240-0.3340.900.731
2024Q42025-03-20-0.230--0.2310.76--
2024Q32024-11-12---0.2510.67--
2024Q22024-08-09---0.4220.61--
2024Q12024-05-22-0.320--0.3240.65--
2023Q42024-04-09---0.8160.53--
2023Q32023-11-20-1.350-0.170-0.9520.481.411
2023Q22023-09-21-1.210-0.220-1.2360.651.021
2023Q12023-08-22-0.380--0.3850.81--
2026Q4---0.250--2.201

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY--0.930-2.2472.464.85
2024FY-1.200--1.2222.69-
2025FY-0.950-1.000-0.8603.573.45
2026FY--0.810--7.80
2027FY--0.560--15.70
2028FY-0.010--30.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-091012.202.202.20
2026Q4S2026-10-251002.602.602.60
2026Q4S2026-09-051012.602.602.60
2026Q4S2026-08-112013.002.603.40
2026Q4S2026-07-052003.503.403.60
2026Q4S2026-05-122013.503.403.60
2026Q4S2026-04-212013.503.403.60
2026Q4S2026-03-192103.553.403.70
2026Q4S2026-03-041003.203.203.20
2026Q4S2025-12-191103.203.203.20
2026Q4S2025-11-121103.103.103.10
2026Q4S2025-11-111103.103.103.10
2026Q4S2025-11-101013.003.003.00
2026Q4S2025-11-091013.003.003.00

Estimate history

EPS, annual-0.703-0.615-0.903-2.247-1.222-0.948-1.0638
Period202020212022202320242025TTM
EPS, quarterly-0.251-0.231-0.334-0.223-0.235-0.179-0.178-0.188-0.519
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1.932.7212.6852.462.6863.5696.53
Period202020212022202320242025TTM
Sales, quarterly0.6670.7610.8960.8940.8110.9681.6081.9292.028
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual6.146.146.146.5096.9910.65313.808
Period202020212022202320242025MRQ
Shares, quarterly6.986.997.2169.8599.88610.65311.4512.46813.808
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue6.533.572.692.462.682.721.93
Cost of Goods Sold Incl. D&A0.900.560.360.300.300.470.48
Gross Profit5.633.012.322.162.392.251.45
Selling, General and Administrative Excl. Other17.7910.219.488.825.765.225.57
Research and Development0.810.490.210.170.230.200.17
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-12.16-7.20-7.16-6.66-3.37-2.97-4.12
Interest Expense0.090.100.535.362.740.040.08
Unusual Expense0.040.640.002.61-1.320.03-0.22
Net Income Before Taxes-12.10-7.80-8.24-14.63-4.78-3.03-3.73
Income Taxes0.000.000.000.000.000.000.00
Consolidated Net Income-12.10-7.80-8.24-14.63-4.78-3.03-3.73
Net Income From Continuing Operations-12.10-7.80-8.24-14.63-4.78-3.03-3.73
Net Income-12.87-8.62-8.45-14.63-5.54-3.78-4.32
EPS (Recurring)-0.99-0.90-1.22-1.97-1.05-0.61-0.73
EPS (Basic, Before Extraordinaries)-1.06-0.95-1.22-2.25-0.90-0.62-0.70
EPS (Diluted)-1.06-0.95-1.22-2.25-0.90-0.62-0.70
EBITDA-12.09-7.14-7.12-6.62-3.31-2.91-4.07
Non-Operating Income (Expense)0.190.14-0.550.000.010.010.25
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense1.130.600.230.000.030.050.05
Price To Sales Ratio14.6511.556.057.06---
Gross Margin86.1684.2386.5287.6788.9482.8175.08
Operating Margin-186.16-201.70-266.46-270.91-125.61-109.14-213.48
Net Margin-197.02-241.37-314.71-594.57-206.54-138.79-223.56
Shares Outstanding13.8110.656.996.516.146.146.14
Market Capitalization75.7275.7216.4013.7513.75--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue2.031.931.610.970.810.890.900.76
Cost of Goods Sold Incl. D&A0.270.270.220.140.140.150.140.11
Gross Profit1.761.661.390.830.680.750.760.66
Selling, General and Administrative Excl. Other8.343.783.132.542.782.473.052.12
Research and Development0.290.270.100.150.130.060.060.07
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.58-2.12-1.74-1.72-2.10-1.72-2.30-1.47
Interest Expense0.020.020.030.030.060.010.000.00
Unusual Expense0.00-0.000.030.010.000.00-0.00-0.01
Net Income Before Taxes-6.55-2.09-1.76-1.71-2.12-1.69-2.28-1.45
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-6.55-2.09-1.76-1.71-2.12-1.69-2.28-1.45
Net Income From Continuing Operations-6.55-2.09-1.76-1.71-2.12-1.69-2.28-1.45
Net Income-6.74-2.28-1.95-1.90-2.32-1.90-2.49-1.61
EPS (Recurring)-0.52-0.19-0.18-0.18-0.23-0.22-0.33-0.23
EPS (Basic, Before Extraordinaries)-0.52-0.19-0.18-0.18-0.23-0.22-0.33-0.23
EPS (Diluted)-0.52-0.19-0.18-0.18-0.23-0.22-0.33-0.23
EBITDA-6.56-2.11-1.72-1.69-2.08-1.70-2.29-1.46
Non-Operating Income (Expense)0.060.060.040.040.040.040.020.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.000.640.330.160.160.170.11-
Price To Sales Ratio14.6516.6718.9213.559.056.415.476.12
Gross Margin86.6085.8786.4285.3783.3083.6084.4386.20
Operating Margin-324.42-110.16-108.26-177.34-258.82-192.14-256.25-192.68
Net Margin-332.32-118.07-121.33-196.62-286.11-212.27-278.26-212.09
Shares Outstanding13.8112.4711.4510.659.899.867.226.99
Market Capitalization75.7290.5382.7948.3630.4121.1915.5116.40

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments4.973.700.080.250.321.90
Short Term Receivables0.200.240.070.170.120.31
Inventories0.260.040.020.050.040.11
Other Current Assets0.320.280.070.000.020.15
Total Current Assets5.734.270.240.480.492.46
Net Property, Plant & Equipment0.340.370.160.190.250.30
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.270.100.110.080.020.03
Other Assets0.060.020.000.740.000.00
Total Assets6.404.760.511.480.762.79
Short Term Debt Incl. Current Port. of LT Debt0.210.220.200.520.280.17
Accounts Payable0.140.601.201.590.480.16
Income Tax Payable---0.000.000.00
Other Current Liabilities2.441.620.484.860.660.67
Total Current Liabilities2.792.431.896.981.421.01
Long Term Debt0.200.260.030.080.160.14
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.010.000.000.000.000.00
Total Liabilities3.002.691.917.051.591.15
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3.402.06-1.40-5.57-0.831.64
Total Shareholders Equity3.402.07-1.40-5.57-0.831.64
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3.402.07-1.40-5.57-0.831.64
Total Liabilities & Stockholders Equity6.404.760.511.480.762.79
Book Value Per Share0.320.30-0.22-0.91-0.130.27
Tangible Book Value Per Share0.290.28-0.23-0.92-0.140.26
Full-Time Employees242119---
Price to Book Ratio23.01-9.13-12.96-12.96--
Return on Assets-139.77-312.94-1,469.91-426.58-170.59-
Return on Equity-285.36-2,480.49---740.29-
Return on Invested Capital-216.57-354.59----209.23
Quick Ratio1.961.740.120.060.322.33
Current Ratio2.051.750.130.070.342.44

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-12.10-7.80-8.24-14.63-4.78-3.03-3.73
Depreciation0.070.060.040.040.060.060.06
Other Funds (Non Cash)6.250.701.968.561.150.09-0.17
Funds from Operations-5.78-7.04-6.24-6.03-3.57-2.88-3.84
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-0.680.610.14-0.671.270.64-0.30
Cash from Operating Activities-6.46-6.43-6.10-6.69-2.30-2.23-4.14
Capital Expenditures-0.13-0.13-0.03-0.07-0.06-0.00-0.03
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities-0.13-0.13-0.03-0.07-0.06-0.00-0.03
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock9.568.115.285.06-0.740.516.77
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock9.568.115.285.06-0.740.516.77
Proceedsfrom Stock Options8.407.025.254.85-0.740.516.77
Issuance or Reduction of Debt, Net-0.24-0.284.662.093.030.15-0.72
Change in Long Term Debt-0.06-0.284.662.093.030.15-0.72
Issuance of Long Term Debt0.000.004.945.623.190.250.47
Reduction of Long Term Debt-0.06-0.28-0.28-3.53-0.16-0.10-1.19
Net Financing Active Other Cash Flow-2.640.00-0.19-0.550.000.000.00
Other Financing Activities Uses-2.640.00-0.19-0.550.000.000.00
Cash from Financing Activities6.697.839.746.592.290.666.05
Net Change in Cash0.101.273.62-0.18-0.07-1.571.89
Free Cash Flow-6.47-6.46-6.13-6.72-2.30-2.24-4.17
Preferred Dividends (Cash Flow)---0.00---
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments4.488.327.084.974.385.99
Short Term Receivables0.810.430.390.200.110.13
Inventories0.250.280.240.260.110.13
Other Current Assets0.510.380.440.320.390.37
Total Current Assets6.059.418.145.734.996.62
Net Property, Plant & Equipment0.270.290.310.340.360.36
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.260.260.270.270.280.09
Other Assets0.070.030.020.060.140.02
Total Assets6.6610.008.756.405.787.09
Short Term Debt Incl. Current Port. of LT Debt0.280.110.170.210.260.19
Accounts Payable0.400.790.310.140.890.46
Other Current Liabilities2.212.192.342.442.001.69
Total Current Liabilities2.893.102.812.793.152.35
Long Term Debt0.140.160.180.200.220.22
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.010.120.27
Total Liabilities3.033.263.003.003.492.83
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3.626.735.743.402.284.25
Total Shareholders Equity3.626.745.753.402.284.25
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3.626.745.753.402.284.25
Total Liabilities & Stockholders Equity6.6610.008.756.405.787.09
Book Value Per Share0.260.540.500.320.230.43
Tangible Book Value Per Share0.240.520.480.290.200.42
Full-Time Employees---24--
Price to Book Ratio23.0113.5414.7519.687.1568.69
Return on Assets-194.69-89.89-123.70-139.77-217.92-147.56
Return on Equity-409.70-139.76-242.53-285.36-3,071.15-
Return on Invested Capital-173.75-30.23-29.70-47.44-84.75-37.79
Quick Ratio2.012.952.811.961.552.76
Current Ratio2.103.042.892.051.582.82

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-6.55-2.09-1.76-1.71-2.12-1.69
Depreciation0.020.020.020.020.020.01
Other Funds (Non Cash)4.910.730.420.190.190.20
Funds from Operations-1.61-1.34-1.32-1.50-1.91-1.48
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.650.310.09-0.440.490.01
Cash from Operating Activities-2.27-1.03-1.23-1.93-1.43-1.47
Capital Expenditures-0.01-0.010.00-0.110.00-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.01-0.010.00-0.110.00-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock1.512.533.412.110.006.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock1.512.533.412.110.006.00
Proceedsfrom Stock Options1.472.012.902.020.005.00
Issuance or Reduction of Debt, Net-0.07-0.06-0.06-0.06-0.07-0.09
Change in Long Term Debt0.000.000.00-0.06-0.07-0.09
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.00-0.06-0.07-0.09
Net Financing Active Other Cash Flow-3.01-0.19-0.010.57-0.11-0.46
Other Financing Activities Uses-3.01-0.19-0.010.57-0.11-0.46
Cash from Financing Activities-1.562.283.342.63-0.185.46
Net Change in Cash-3.851.242.110.59-1.613.98
Free Cash Flow-2.27-1.04-1.23-1.94-1.43-1.47

Revenue breakdown

Electromedical & Electrotherapeutic Apparatus2024: 2.69M 2025: 3.57M
All other States2024: 767.99K 2025: 1.25M
California2024: 778.21K 2025: 898.22K
Florida2024: 149.99K 2025: 143.95K
Illinois2024: 246.22K 2025: 222.39K
MASSACHUSETTS2024: 154.41K 2025: 265.20K
Ohio2024: 431.33K 2025: 578.77K
WISCONSIN2024: 157.79K 2025: 215.43K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.33%0.5M8.6M127.95K
2026-10-154.83%0.4M8.6M125.07K
2026-09-304.36%0.4M8.6M106.02K
2026-09-154.41%0.4M8.6M82.47K
2026-08-312.92%0.2M8.5M93.90K
2026-08-144.50%0.4M9.1M100.34K
2026-07-314.56%0.4M9.2M119.93K
2026-07-155.14%0.5M9.2M140.70K
2026-06-303.92%0.4M9.2M149.83K
2026-06-155.54%0.5M9.2M181.25K
2026-05-295.84%0.5M8.9M184.95K
2026-05-154.52%0.4M8.9M192.57K
2026-04-304.81%0.4M8.2M164.77K
2026-04-153.29%0.3M8.0M147.66K
2026-03-312.29%0.2M7.9M149.51K
2026-03-131.94%0.2M7.9M389.35K
2026-02-271.69%0.1M7.5M363.05K
2026-02-132.35%0.2M7.5M351.28K
2026-01-301.46%0.1M7.6M359.82K
2026-01-152.33%0.2M7.7M671.76K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.503.004.200.0010.6430.000.000.903-0.0890.001
call5.000.701.502.403.48761.000.000.702-0.0690.003
call7.500.001.401.705.78318.000.000.544-0.1230.003
call10.000.000.750.115.1095010.000.363-0.1030.003
call12.500.003.400.006.0710.000.000.334-0.1190.003
put2.500.003.400.009.6130.000.00-0.097-0.0890.001
put5.000.000.800.043.6674.000.00-0.298-0.0680.003
put7.501.052.000.052.2504.000.00-0.456-0.1230.003
put10.003.304.502.323.44110.000.00-0.637-0.1030.003
put12.505.807.000.004.2520.000.00-0.666-0.1180.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13G/ASEC
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-148-KCurrent report2026-10-14SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-08SEC
2026-09-293Initial statement of beneficial ownership of securities2026-09-28SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-198-KCurrent report2026-07-24SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-06424B3SEC
2026-08-03EFFECTEffectiveness filing by commission orderSEC
2026-08-03SCHEDULE 13G/ASEC
2026-07-30S-3/ASEC
2026-07-23S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-10S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-108-KCurrent report2026-07-09SEC
2026-06-128-KCurrent report2026-06-10SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-01SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1012.26K300
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-0431.99K300
2026-030000
2026-02382.80K200
2026-010000
2025-121.01M100
2025-110000

Institutional holders

Manager% owned
AIGH Capital Management LLC4.30%
Rosalind Advisors, Inc.4.10%
VANGUARD CAPITAL MANAGEMENT LLC2.71%
MONEY CONCEPTS CAPITAL CORP1.88%
RENAISSANCE TECHNOLOGIES LLC1.37%
MARSHALL WACE, LLP1.04%
Panoramic Capital, LLC0.93%
GEODE CAPITAL MANAGEMENT, LLC0.72%
PARSONS CAPITAL MANAGEMENT INC/RI0.72%
CITADEL ADVISORS LLC0.69%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.80%
VANGUARD EXTENDED MARKET INDEX FUND0.81%
Fidelity Extended Market Index Fund0.35%
iShares Micro-Cap ETF0.24%
Ultra-Small Company Market Fund0.14%
Fidelity Series Total Market Index Fund0.13%
Fidelity Total Market Index Fund0.12%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.06%
VANGUARD BALANCED INDEX FUND0.03%
1290 VT Micro Cap Portfolio0.02%

OakChart. NRXS. Cached 15 minutes. Terms

Some panels did not load: ratings.